Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Intervalo de año de publicación
1.
Eur J Pharm Sci ; 188: 106508, 2023 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-37379779

RESUMEN

Miconazole-loaded nanoparticles coated with hyaluronic acid (miconazole-loaded nanoparticles/HA) were developed to overcome the limitations of the conventional therapy of the vulvovaginal candidiasis (VVC). They were synthesized by emulsification and solvent evaporation techniques, characterized by diameter, polydispersity index, zeta potential, encapsulation efficiency, atomic force microscopy (AFM), evaluated in terms of efficacy against C. albicans in vitro, and tested in a murine VVC model. Nanoparticles showed 211nm of diameter with a 0.32 polydispersity index, -53mV of zeta potential, and 90% miconazole encapsulation efficiency. AFM evidenced nanoparticles with a spherical shape. They inhibited the proliferation of C. albicans in vitro and in vivo after a single administration. Nanoparticles released the miconazole directly in the site of action at low therapeutic doses, which was enough to eliminate the fungal burden in the murine VVC model. These systems were rationally designed since the existence of the HA induces their adhesion on the vaginal mucus and their internalization via CD44 receptors, inhibiting the C. albicans. Therefore, miconazole-loaded nanoparticles/HA represent an innovative non-conventional pharmaceutical dosage form to treat the VVC and recurrent VVC.


Asunto(s)
Candidiasis Vulvovaginal , Nanopartículas , Humanos , Femenino , Ratones , Animales , Miconazol/uso terapéutico , Candidiasis Vulvovaginal/tratamiento farmacológico , Ácido Hialurónico , Antifúngicos , Candida albicans
2.
Braz. J. Pharm. Sci. (Online) ; 59: e22111, 2023. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1439497

RESUMEN

Abstract Chagas disease is a neglected parasitic disease caused by Trypanosoma cruzi, whose treatment has remained unsatisfactory for over 50 years, given that it is limited to two drugs. Benznidazole (BZN) is an efficient antichagasic drug used as the first choice, although its poor water-solubility, irregular oral absorption, low efficacy in the chronic phase, and various associated adverse effects are limiting factors for treatment. Incorporating drugs with such characteristics into nanostructured lipid carriers (NLC) is a promising alternative to overcome these limiting obstacles, enhancing drug efficacy and bioavailability while reducing toxicity. Therefore, this study proposed NLC-BZN formulations in different compositions prepared by hot-melt homogenization followed by ultrasound, and the optimized formulation was characterized by FTIR, DRX, DSC, and thermogravimetry. Biological activities included in vitro membrane toxicity (red blood cells), fibroblast cell cytotoxicity, and trypanocidal activity against epimastigotes of the Colombian strain of T. cruzi. The optimized NLC-BZN had a small size (110 nm), negative zeta potential (-18.0 mV), and high encapsulation (1.64% of drug loading), as shown by infrared spectroscopy, X-ray diffraction, and thermal analysis. The NLC-BZN also promoted lower in vitro membrane toxicity (<3% hemolysis), and 50% cytotoxic concentration (CC50) for NLC-BZN in L929 fibroblast cells (110.7 µg/mL) was twice the value as the free BZN (51.3 µg/mL). Our findings showed that the NLC-BZN had higher trypanocidal activity than free BZN against the epimastigotes of the resistant Colombian strain, and this novel NLC-BZN formulation proved to be a promising tool in treating Chagas disease and considered suitable for oral and parenteral administration


Asunto(s)
Trypanosoma cruzi/aislamiento & purificación , Difracción de Rayos X/instrumentación , Enfermedad de Chagas/patología , Enfermedades Desatendidas/clasificación , Enfermedades Parasitarias/patología , Análisis Espectral/instrumentación , Esguinces y Distensiones/clasificación , Termogravimetría/métodos , Técnicas In Vitro/métodos , Preparaciones Farmacéuticas/análisis , Espectroscopía Infrarroja por Transformada de Fourier/métodos
3.
Int J Biol Macromol ; 169: 330-341, 2021 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-33310092

RESUMEN

Vancomycin-loaded N,N-dodecyl,methyl-polyethylenimine nanoparticles coated with hyaluronic acid (VCM-DMPEI nanoparticles/HA) were synthesized as an adjuvant for the treatment of bacterial endophthalmitis. The nanoparticles were formulated by experimental statistical design, thoroughly characterized, and evaluated in terms of bactericidal activity and both in vitro and in vivo ocular biocompatibility. The VCM-DMPEI nanoparticles/HA were 154 ± 3 nm in diameter with a 0.197 ± 0.020 polydispersity index; had a + 26.4 ± 3.3 mV zeta potential; exhibited a 93% VCM encapsulation efficiency; and released 58% of the encapsulated VCM over 96 h. VCM and DMPEI exhibited a synergistic bactericidal effect. The VCM-DMPEI nanoparticles/HA were neither toxic to ARPE-19 cells nor irritating to the chorioallantoic membrane. Moreover, the VCM-DMPEI nanoparticles/HA did not induce modifications in retinal functions, as determined by electroretinography, and in the morphology of the ocular tissues. In conclusion, the VCM-DMPEI nanoparticles/HA may be a useful therapeutic adjuvant to treat bacterial endophthalmitis.


Asunto(s)
Endoftalmitis/tratamiento farmacológico , Polietileneimina/análogos & derivados , Vancomicina/farmacología , Antibacterianos/farmacología , Línea Celular , Portadores de Fármacos , Liberación de Fármacos , Ojo/efectos de los fármacos , Humanos , Ácido Hialurónico/metabolismo , Ácido Hialurónico/farmacología , Nanopartículas , Tamaño de la Partícula , Polietileneimina/química , Polietileneimina/farmacología , Vancomicina/química
4.
Expert Opin Drug Discov ; 15(7): 853-864, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32290727

RESUMEN

INTRODUCTION: Most drugs used in therapy have low water-solubility, a factor that could reduce their dissolution rate and oral bioavailability, representing a challenge in pharmaceutical development. Nanonization of drugs is the reduction of particles to nanoscale, increasing the surface area and consequently the saturation solubility and dissolution rate and resulting in higher bioavailability. AREAS COVERED: This review provides an overview of the consequences of the poor water-solubility and the main strategies applied to increase the solubility of poorly water-soluble drugs. The relationship between the biopharmaceutical classification system and the solubilization process of the drug is also considered. Finally, it includes how drug nanoparticles and nanocarriers, especially lipid-based nanosystems, can overcome these challenges and which of these approaches are already available on the market. EXPERT OPINION: Due to the growing importance of nanomedicines, especially for applications in poorly water-soluble drugs, it is important to clearly establish the specifications and quality criteria for nanonized drugs to ensure the quality and safety of nanoparticles.


Asunto(s)
Nanopartículas , Preparaciones Farmacéuticas/administración & dosificación , Administración Oral , Disponibilidad Biológica , Química Farmacéutica , Portadores de Fármacos/química , Desarrollo de Medicamentos , Humanos , Lípidos/química , Preparaciones Farmacéuticas/química , Preparaciones Farmacéuticas/clasificación , Solubilidad , Agua/química
5.
Braz. J. Pharm. Sci. (Online) ; 53(1): e15235, 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-839451

RESUMEN

Abstract A novel series of platinum (II) complexes was synthesized and the complexes were evaluated for their in vitro cytotoxicity against four human cancer cells lines. Five platinum complexes showed activity against at least one tumor cell line. Complexes 3 and 6 were promising, being active, at micromolar concentrations, against all the assayed tumor cell lines. Compound 3 was selected for further studies in mice with Ehrlich solid tumors and it was able to reduce the rate of tumor growth significantly during the first seven days. However, at the end of the experiments, there was no significant difference between the group of animals treated with 3 and the control group. The low solubility of the compound in the assay conditions can explain, at least in part, these results.


Asunto(s)
Animales , Masculino , Femenino , Ratas , Platino (Metal)/análisis , Ensayos de Selección de Medicamentos Antitumorales/instrumentación , Pruebas Inmunológicas de Citotoxicidad/clasificación , Carcinoma de Ehrlich/clasificación , Citotoxinas/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA